Search research articles
Contact Us
Filters
Showing results (281-290 of 419) with videos related to
Page
of 42
Sort By:
Journal of Medical Internet Research
|
July 7, 2020
A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development
Erica Schleimer, Jennifer Pearce, Andrew Barnecut, et al.
Human Molecular Genetics
|
May 15, 2010
Refining the association of MHC with multiple sclerosis in African Americans
Joseph P McElroy, Bruce A C Cree, Stacy J Caillier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 30, 2011
Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation
Jacob Glanville, Tracy C Kuo, H-Christian von Büdingen, et al.
Therapeutic Advances in Neurological Disorders
|
October 14, 2024
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials
Tobias Derfuss, Robert Bermel, Chien-Ju Lin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 19, 2023
CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity
Sasha Gupta, Milos Simic, Sharon A Sagan, et al.
Genes and Immunity
|
August 2, 2013
Genetic burden in multiple sclerosis families
N Isobe, V Damotte, V Lo Re, et al.
Journal of Medicinal Chemistry
|
May 9, 1997
Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator
A D Palkowitz, A L Glasebrook, K J Thrasher, et al.
Neurology and Therapy
|
July 14, 2023
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
Stephen L Hauser, Ludwig Kappos, Amit Bar-Or, et al.
Immunogenetics
|
May 10, 2000
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group
L F Barcellos, A M Schito, J B Rimmler, et al.
Annals of Neurology
|
June 17, 2018
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
Xiaoming Jia, Lohith Madireddy, Stacy Caillier, et al.
Page
of 42
Search research articles
Search
Showing results (281-290 of 419) with videos related to
Sort By:
Page
of 42
Journal of Medical Internet Research
|
July 7, 2020
A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development
Erica Schleimer, Jennifer Pearce, Andrew Barnecut, et al.
Human Molecular Genetics
|
May 15, 2010
Refining the association of MHC with multiple sclerosis in African Americans
Joseph P McElroy, Bruce A C Cree, Stacy J Caillier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 30, 2011
Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation
Jacob Glanville, Tracy C Kuo, H-Christian von Büdingen, et al.
Therapeutic Advances in Neurological Disorders
|
October 14, 2024
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials
Tobias Derfuss, Robert Bermel, Chien-Ju Lin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 19, 2023
CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity
Sasha Gupta, Milos Simic, Sharon A Sagan, et al.
Genes and Immunity
|
August 2, 2013
Genetic burden in multiple sclerosis families
N Isobe, V Damotte, V Lo Re, et al.
Journal of Medicinal Chemistry
|
May 9, 1997
Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator
A D Palkowitz, A L Glasebrook, K J Thrasher, et al.
Neurology and Therapy
|
July 14, 2023
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
Stephen L Hauser, Ludwig Kappos, Amit Bar-Or, et al.
Immunogenetics
|
May 10, 2000
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group
L F Barcellos, A M Schito, J B Rimmler, et al.
Annals of Neurology
|
June 17, 2018
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
Xiaoming Jia, Lohith Madireddy, Stacy Caillier, et al.
Page
of 42